- Home
- ME vs CBUS Comparison
ME vs CBUS Comparison
Compare ME & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ME
- CBUS
- Stock Information
- Founded
- ME 2006
- CBUS 2010
- Country
- ME United States
- CBUS United States
- Employees
- ME N/A
- CBUS N/A
- Industry
- ME Precision Instruments
- CBUS Agricultural Chemicals
- Sector
- ME Health Care
- CBUS Industrials
- Exchange
- ME Nasdaq
- CBUS Nasdaq
- Market Cap
- ME 168.9M
- CBUS 160.8M
- IPO Year
- ME N/A
- CBUS 2017
- Fundamental
- Price
- ME $0.35
- CBUS $5.01
- Analyst Decision
- ME Hold
- CBUS Strong Buy
- Analyst Count
- ME 1
- CBUS 3
- Target Price
- ME $0.47
- CBUS $23.67
- AVG Volume (30 Days)
- ME 2.3M
- CBUS 141.8K
- Earning Date
- ME 11-06-2024
- CBUS 11-07-2024
- Dividend Yield
- ME N/A
- CBUS N/A
- EPS Growth
- ME N/A
- CBUS N/A
- EPS
- ME N/A
- CBUS N/A
- Revenue
- ME $199,188,000.00
- CBUS $2,961,000.00
- Revenue This Year
- ME $0.05
- CBUS $36.93
- Revenue Next Year
- ME $17.98
- CBUS $236.45
- P/E Ratio
- ME N/A
- CBUS N/A
- Revenue Growth
- ME N/A
- CBUS 816.72
- 52 Week Low
- ME $0.29
- CBUS $4.26
- 52 Week High
- ME $1.10
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- ME 58.52
- CBUS 36.94
- Support Level
- ME $0.29
- CBUS $4.77
- Resistance Level
- ME $0.32
- CBUS $5.58
- Average True Range (ATR)
- ME 0.02
- CBUS 0.62
- MACD
- ME 0.01
- CBUS 0.03
- Stochastic Oscillator
- ME 100.00
- CBUS 29.57
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.